Danish (OMX) Biotech Industry Analysis

UpdatedMar 09, 2026

DataAggregated Company Financials

Companies5

7D-11.4%
3M-23.1%
1Y-10.4%
YTD-19.8%

Over the last 7 days, the Biotech industry has dropped 11%, driven by a pullback from Zealand Pharma of 35%. Overall the industry is down 10% in 12 months. Looking forward, earnings are forecast to grow by 2.5% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Mon, 09 Mar 2026	DKK 137.5b	DKK 40.1b	DKK 15.0b	5.8x	9.2x	3.4x
Wed, 04 Feb 2026	DKK 175.6b	DKK 40.4b	DKK 18.9b	6.3x	9.3x	4.3x
Fri, 02 Jan 2026	DKK 173.2b	DKK 40.5b	DKK 19.0b	6.1x	9.1x	4.3x
Sun, 30 Nov 2025	DKK 176.9b	DKK 40.8b	DKK 19.1b	5.9x	9.3x	4.3x
Tue, 28 Oct 2025	DKK 166.9b	DKK 39.0b	DKK 16.8b	13.1x	9.9x	4.3x
Thu, 25 Sep 2025	DKK 166.7b	DKK 38.8b	DKK 16.7b	12.7x	10x	4.3x
Sat, 23 Aug 2025	DKK 145.1b	DKK 38.6b	DKK 16.6b	11.1x	8.7x	3.8x
Mon, 21 Jul 2025	DKK 128.1b	DKK 27.1b	DKK 7.4b	11.4x	17.4x	4.7x
Wed, 18 Jun 2025	DKK 129.8b	DKK 27.3b	DKK 7.5b	11.1x	17.4x	4.8x
Fri, 16 May 2025	DKK 122.1b	DKK 28.0b	DKK 7.9b	9.9x	15.5x	4.4x
Sun, 13 Apr 2025	DKK 119.9b	DKK 27.3b	DKK 7.7b	10.7x	15.6x	4.4x
Tue, 11 Mar 2025	DKK 146.1b	DKK 27.3b	DKK 7.7b	12.7x	19x	5.3x
Thu, 06 Feb 2025	DKK 150.7b	DKK 26.0b	DKK 4.7b	15.5x	32.1x	5.8x
Sat, 04 Jan 2025	DKK 165.3b	DKK 26.0b	DKK 4.7b	17.5x	35.2x	6.4x
Mon, 02 Dec 2024	DKK 164.4b	DKK 26.0b	DKK 4.7b	17.1x	35x	6.3x
Wed, 30 Oct 2024	DKK 176.5b	DKK 25.5b	DKK 5.5b	21.2x	32.2x	6.9x
Fri, 27 Sep 2024	DKK 179.8b	DKK 25.5b	DKK 5.5b	22.3x	32.8x	7.1x
Sun, 25 Aug 2024	DKK 200.1b	DKK 25.5b	DKK 5.5b	25.7x	36.7x	7.8x
Tue, 23 Jul 2024	DKK 197.2b	DKK 24.8b	DKK 5.6b	18.4x	35x	8x
Thu, 20 Jun 2024	DKK 166.3b	DKK 24.8b	DKK 5.6b	16.4x	29.5x	6.7x
Sat, 18 May 2024	DKK 183.8b	DKK 24.8b	DKK 5.6b	19.1x	32.6x	7.4x
Mon, 15 Apr 2024	DKK 183.5b	DKK 23.9b	DKK 5.0b	19.4x	36.4x	7.7x
Wed, 13 Mar 2024	DKK 196.1b	DKK 23.9b	DKK 5.0b	20.4x	39x	8.2x
Fri, 09 Feb 2024	DKK 167.8b	DKK 23.3b	DKK 4.2b	23x	40.3x	7.2x
Sun, 07 Jan 2024	DKK 177.7b	DKK 23.3b	DKK 4.2b	26x	42.7x	7.6x
Tue, 05 Dec 2023	DKK 177.1b	DKK 23.3b	DKK 4.2b	25.6x	42.5x	7.6x
Thu, 02 Nov 2023	DKK 158.1b	DKK 22.0b	DKK 4.7b	19.1x	33.4x	7.2x
Sat, 30 Sep 2023	DKK 194.6b	DKK 22.0b	DKK 4.7b	23x	41.1x	8.8x
Mon, 28 Aug 2023	DKK 196.4b	DKK 22.0b	DKK 4.7b	23.3x	41.6x	8.9x
Wed, 26 Jul 2023	DKK 198.6b	DKK 19.5b	DKK 4.4b	35.1x	45.1x	10.2x
Fri, 23 Jun 2023	DKK 202.6b	DKK 19.5b	DKK 4.4b	42.7x	46x	10.4x
Sun, 21 May 2023	DKK 216.2b	DKK 19.5b	DKK 4.4b	44.1x	49.1x	11.1x
Tue, 18 Apr 2023	DKK 218.0b	DKK 17.9b	DKK 3.5b	34.3x	61.6x	12.2x
Thu, 16 Mar 2023	DKK 190.8b	DKK 17.9b	DKK 3.5b	29.7x	53.8x	10.6x

Price to Earnings Ratio

53.8x

Thu, 16 Mar 2023

Current Industry PE

Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 9.2x which is lower than its 3-year average PE of 30.5x.

The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 3.4x.

Past Earnings Growth

The earnings for companies in the Biotechs industry have grown 62% per year over the last three years.
Revenues for these companies have grown 31% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.